We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
We will prescribe you anti-sickness medication if needed.
We will also help you create a pregnancy care plan, and discuss your options for screening tests.
Why we are introducing this new type of follow-up?
We have been very fortunate in having Peter in Oxford spearheading this service.
In terms of COVID-19, we have assessed the event and are confident it presents little risk to the public.
If you need further advice, we suggest starting with the exercises on our website: www.gloshospitals.nhs.uk/pain More specific advice and self-referral
We have launched a Prehabilitation service that offers pre-treatment support for patients with cancer.
By doing so, we can dramatically improve someone's health and wellbeing, boost their chances of recovery from treatment, and reduce hospital admissions
We launched the £600,000 appeal in October, and have been bowled over by the support so far.
We deliberately say ‘can help’ because the tests are not perfect. In other words, no tests can guarantee a perfect outcome.
Please contact the laboratory in advance of sending any specimens so that we can ensure that the correct procedures are understood and followed.
We will look carefully at your skin and a first reading will be made.
“The inspection highlighted a number of areas where we need to focus our work, and we have already taken steps to ensure better process are in place to
At the NHS, we want our patients to have the best experience possible and having continuous patient feedback is crucial in helping us deliver what patients
For the first time, we have genuine human obtained artificial intelligence improving our images to an amazing quality we have never seen before.”
Without the dedication of our colleagues we would be unable to provide the care we do to our patients.
The Quality Improvement Programme is about being the best that we can be.
How we hear
Department of Immunology Notes We no longer offer this assay as it is no longer recommended as a screening tool for myeloma.